Skip to content
GLP-1 Savers
Menu
Ranked #32 · Good Value

REMEVi review

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $219/mo

Save ~84% vs brand-name

$219/mo (all doses, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The rate is stated as the same at every dose, but it is not a plain month-to-month figure.

How much does REMEVi cost?

The price REMEVi publishes is $219/mo (all doses, compounded). Tirzepatide is listed at $319/mo (all doses, compounded). We flag this one to watch: confirm the ongoing rate with REMEVi before you count on it, because a low first month can step up afterward. That works out about 84% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$219/mo (all doses, compounded)
Tirzepatide
$319/mo (all doses, compounded)
Coverage
All 50 states
Brand-name
Compounded only

The Value Score card

REMEVi scored on our six published factors. See the methodology.

Lowest Real Price68/100
No Teaser-Rate Bait90/100
Nationwide Availability96/100
Both Molecules98/100
Easy Cancellation95/100
Reputation87/100

Why it's a deal

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

Read the fine print

  • The flat rate is one of the highest entry prices in this ranking; the cheaper $149 figure needs a full year
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

The bottom line

Best for: Shoppers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Ranked #32 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to REMEVi, out of 426 others we track.

Shopping REMEVi against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs REMEVi, and every program that undercuts or outscores it — starting with MyFastRx, the closest match on score — is ranked on the REMEVi alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from REMEVi's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

Where REMEVi ranks

See every program ranked by price →

← Back to all deals